Famotidine

Excerpt

Famotidine reduces gastric acid secretion in individuals, and its pharmacological properties are utilized in treating gastrointestinal conditions related to excessive acid production. Famotidine can be obtained through a prescription or bought over-the-counter (OTC). The U.S. Food and Drug Administration (FDA) has approved famotidine as a prescription medication for treating duodenal ulcers, gastric ulcers, and gastroesophageal reflux disease (GERD) in adults and children, as well as pathological hypersecretory conditions in adults. The drug has also received FDA approval for OTC usage for treating and preventing heartburn caused by GERD in adults and pediatric populations. The drug is also off-label to treat refractory urticaria, prevent stress ulcers in critically ill patients, and provide symptomatic relief for gastritis. This activity outlines the indications, mechanisms of action, administration methods, significant adverse effects, contraindications, monitoring recommendations, and toxicity of famotidine to enhance the competence of healthcare providers, empowering providers to customize patient therapy and ensure favorable treatment outcomes effectively.